Skip to content

Drug interactions

Lasmiditan + Topotecan

Severity: Moderate

Lasmiditan and Topotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lasmiditan inhibits P-gp and BCRP in vitro, and topotecan is a substrate of both transporters. Exposure to topotecan may rise, though clinical data are lacking.

What this interaction means in plain words

Lasmiditan and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lasmiditan belongs to Central Nervous System; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Lasmiditan inhibits P-gp and BCRP efflux of topotecan.

What to do

Avoid with oral topotecan; with IV topotecan, monitor blood counts and consider alternative migraine therapy during chemotherapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lasmiditan and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lasmiditan with Topotecan?

MediHelp rates the interaction as moderate. Lasmiditan and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lasmiditan inhibits P-gp and BCRP in vitro, and topotecan is a substrate of both transporters. Exposure to topotecan may rise, though clinical data are lacking.

How serious is the interaction between Lasmiditan and Topotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid with oral topotecan; with IV topotecan, monitor blood counts and consider alternative migraine therapy during chemotherapy.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in